Serum albumin level as an indicator of response to Hepatitis B vaccination in dialysis patients: A systematic review and meta-analysis
Open Access
- 1 July 2017
- journal article
- review article
- Vol. 8 (4), 250-257
- https://doi.org/10.22088/CJIM.8.4.250
Abstract
Hepatitis B (HB) vaccination is a recommended procedure in all dialysis patients, but its efficacy has not been perfect. In the current study, we aimed to conduct a comprehensive review of the literature to find and pool data of the randomized trials evaluating the impact of serum albumin levels on the immunogenicity of HB vaccination in dialysis patients.Literature searches were conducted by the Medline and Google Scholar. The key words used included 'Hepatitis B', 'Vaccine', 'Dialysis', 'Hemodialysis', and 'Albumin'. Data of serum albumin levels regarding seroresponse to HB vaccine in clinical trials have been achieved and analyzed. Finally, data from 17 clinical trials have been pooled and analyzed.One thousand six hundred eighty-two dialysis patients (1212 seroconverted) were included in the meta-analysis. Analysis of response to HB vaccination in our dialysis population showed a significant relationship to their serum albumin levels (p<0.001, z= 5.23). Regarding the dialysis mode, serum albumin level was only a significant interfering factor in hemodialysis patients versus continuous ambulatory peritoneal dialysis (CAPD) (HD group: p<0.001, I2=88.5%, χ2=95.28 (d.f. = 11); CAPD (±HD) group: χ2= 2.21; P=0.697, I2= 0%, d.f.= 4).The data showed a significant effect for the levels of serum albumin on the immunogenicity of HB vaccine in dialysis patients. Moreover, stratification of data upon dialysis mode showed that this association is only available for hemodialysis patients, and not those on peritoneal dialysis.Keywords
This publication has 31 references indexed in Scilit:
- Association of response to hepatitis B vaccination and survival in dialysis patientsBMC Nephrology, 2012
- Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney DiseaseDigestive Diseases and Sciences, 2011
- Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccinationVaccine, 2011
- Meta‐analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patientsAlimentary Pharmacology & Therapeutics, 2010
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- Lack ofde novohepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patientsJournal of Viral Hepatitis, 2009
- Meta‐analysis: the adjuvant role of granulocyte macrophage‐colony stimulating factor on immunological response to hepatitis B virus vaccine in end‐stage renal diseaseAlimentary Pharmacology & Therapeutics, 2006
- Meta‐analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end‐stage renal diseaseAlimentary Pharmacology & Therapeutics, 2006
- Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis populationAlimentary Pharmacology & Therapeutics, 2006
- Meta‐analysis: the effect of age on immunological response to hepatitis B vaccine in end‐stage renal diseaseAlimentary Pharmacology & Therapeutics, 2004